BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27762068)

  • 1. Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation.
    Shah NN; Watson TM; Yates B; Liewehr DJ; Steinberg SM; Jacobsohn D; Fry TJ
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27762068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokine profiles during engraftment syndrome and acute graft-versus-host disease in adult patients after hematopoietic stem cell transplantation.
    Wu B; Jiang C; Jin L; Azadan X; Lin J; Lin L; Nie X; Cai G
    Cytokine; 2024 Jun; 178():156582. PubMed ID: 38493534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.
    Khandelwal P; Mellor-Heineke S; Rehman N; Lane A; Smiley K; Villanueva J; Marsh RA; Grimley MS; Davies SM; Filipovich AH
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):690-697. PubMed ID: 26740373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
    Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
    Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
    Pediatr Blood Cancer; 2015 May; 62(5):890-6. PubMed ID: 25623620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
    Fowler DH; Foley J; Whit-Shan Hou J; Odom J; Castro K; Steinberg SM; Gea-Banacloche J; Kasten-Sportes C; Gress RE; Bishop MR
    Clin Gastroenterol Hepatol; 2004 Mar; 2(3):237-45. PubMed ID: 15017608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation.
    Min CK; Lee WY; Min DJ; Lee DG; Kim YJ; Park YH; Kim HJ; Lee S; Kim DW; Lee JW; Min WS; Kim CC
    Bone Marrow Transplant; 2001 Nov; 28(10):935-40. PubMed ID: 11753547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
    Koreth J; Biernacki M; Aldridge J; Kim HT; Alyea EP; Armand P; Cutler C; Ho VT; Wu CJ; Antin JH; Soiffer RJ
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):421-8. PubMed ID: 20870027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.
    Matsumura A; Miyazaki T; Tachibana T; Ando T; Koyama M; Koyama S; Ishii Y; Takahashi H; Nakajima Y; Numata A; Yamamoto W; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S; Nakajima H
    Turk J Haematol; 2020 Feb; 37(1):20-29. PubMed ID: 31464120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease.
    Sakata N; Yasui M; Okamura T; Inoue M; Yumura-Yagi K; Kawa K
    Bone Marrow Transplant; 2001 Jun; 27(11):1153-61. PubMed ID: 11551026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
    Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
    Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
    Rowan CM; Pike F; Cooke KR; Krance R; Carpenter PA; Duncan C; Jacobsohn DA; Bollard CM; Cruz CRY; Malatpure A; Farag SS; Renbarger J; Liu H; Bakoyannis G; Hanash S; Paczesny S
    Blood; 2020 Apr; 135(17):1428-1437. PubMed ID: 31972009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin and C-reactive protein serum levels after hematopoietic stem-cell transplant.
    Azarpira N; Ramzi M; Aghdaie M; Daraie M
    Exp Clin Transplant; 2009 Jun; 7(2):115-8. PubMed ID: 19715516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease.
    Jung JW; Han SJ; Song MK; Kim TI; Kim EK; Min YH; Cheong JW; Seo KY
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2079-2085. PubMed ID: 26303101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
    Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
    Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I; Stachel D; Pagel P; Albert MH
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
    Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
    Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.